Post by
Lumberfeverlong on Dec 07, 2016 8:37pm
Pfizer Fine was A Fraction of What it Could Have Been
Under its governing statute, the CMA is entitled to impose a fine of up to 10% of a company's global annual revenue. Pfizer generated global revenues of almost $50B USD last year meaning their fine could have been up to $5B. I suspect that Pfizer is very relieved by the outcome and, despite this, it is still appealing the decision. As for Condordia, I think the CMA decision bolds well. First, we still have no indication that the CMA believes Concordia violated any UK competition laws, but assuming they conclude as such, the Pfizer fine suggests any fine imposed will be far less than Concordia's global annual revenue. A $90M USD fine for Concordia would be inconsistent and disproportinal with the fine imposed on Pfizer.
And for those here who are still touting a Chapter 11 filing anytime soon, you know it is mere short wishful thinking. The business will take several quarters to meaninfully recover, but as it stands it is still generating sufficient cash flow to cover operational and debt related expenses.
Finally, people forget that Cinven is Concordia's largest shareholder. It has lost more money than anyone else with the share price tanking over the last several months. I believe we are at an inflection point where they might forgoe payment of the earn-out in order to recoup a much larger amount on the appreciation of the share price. This could be an outright foregiveness of the debt or a conversion into equity. In either scenario, all STAKEHOLDERS, except for shorts, would benefit from a balance sheet improving transaction. I sincerely hope that this is what is keeping management busy these last few weeks. In any event, we will know before Christmas and I sincerely hope it is a good one for all longs and bondholders!
Comment by
juniorbullalive on Dec 07, 2016 10:44pm
This post has been removed in accordance with Community Policy